United States Biotechnology & Medical Research

Vertex Pharmaceuticals Inc (VRTX)

Track

Over the last 90 days, Vertex Pharmaceuticals Inc. has seen 25 insider transactions, with a total sell value of approximately $24 million. Notably, Carmen Bozic, EVP and CMO, has been involved in multiple planned and proposed sales totaling over $3.6 million. Joy Liu, EVP and Chief Legal Officer, also executed planned and proposed sales.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: VRTX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Bozic Carmen

Officer

1 sale — total 100,000 USD

Proposed sale 18 Jun 2026

Value US$1,184,734.31 | Price 351.45 | Shares 38,997

Bozic Carmen

EVP and CMO

3 sales — total 300,000 USD

Planned sale 15 Jun 2026

Value US$1,018,368.28 | Price 411.69 | Shares 80,311

Planned sale 15 Jun 2026

Value US$2,377,407.60 | Price 497.71 | Shares 96,264

Proposed sale 15 Jun 2026

Value US$100,000.00 | Price 450.00 | Shares 1,000

Bozic Carmen

EVP and CMO

2 sales — total 200,000 USD

Planned sale 5 Jun 2026

Value US$100,000.00 | Price 450.00 | Shares 1,000

Proposed sale 5 Jun 2026

Value US$100,000.00 | Price 450.00 | Shares 1,000

Liu Joy

EVP and Chief Legal Officer

2 sales — total 464,245 USD

Planned sale 1 Jun 2026

Value US$100,000.00 | Price 439.91 | Shares 1,000

Proposed sale 1 Jun 2026

Value US$364,245.48 | Price 439.91 | Shares 828

Bozic Carmen

EVP and CMO

2 sales — total 988,300 USD

Planned sale 29 May 2026

Value US$100,000.00 | Price 450.00 | Shares 1,000

Proposed sale 29 May 2026

Value US$888,300.00 | Price 450.00 | Shares 1,974

Bozic Carmen

EVP and CMO

2 sales — total 1,227,943 USD

Planned sale 15 May 2026

Value US$613,971.30 | Price 453.45 | Shares 1,354

Proposed sale 15 May 2026

Value US$613,971.30 | Price 453.45 | Shares 1,354

Bunnage Mark E.

EVP, Chief Scientific Officer

2 sales — total 29,928 USD

Planned sale 15 May 2026

Value US$14,963.85 | Price 453.45 | Shares 33

Proposed sale 15 May 2026

Value US$14,963.85 | Price 453.45 | Shares 33

Bozic Carmen

EVP and CMO

2 sales — total 6,289,200 USD

Planned sale 12 May 2026

Value US$3,144,600.00 | Price 450.00 | Shares 6,988

Proposed sale 12 May 2026

Value US$3,144,600.00 | Price 450.00 | Shares 6,988

Biller Jonathan

Officer

1 sale — total 2,203,149 USD

Proposed sale 6 May 2026

Value US$2,203,149.23 | Price 424.25 | Shares 5,193

Bhatia Sangeeta N.

2 sales — total 269,492 USD

Planned sale 4 May 2026

Value US$134,746.14 | Price 423.73 | Shares 318

Proposed sale 4 May 2026

Value US$134,746.14 | Price 423.73 | Shares 318

Liu Joy

EVP and Chief Legal Officer

2 sales — total 938,444 USD

Planned sale 1 May 2026

Value US$469,222.08 | Price 425.02 | Shares 1,104

Proposed sale 1 May 2026

Value US$469,222.08 | Price 425.02 | Shares 1,104

Liu Joy

EVP and Chief Legal Officer

2 sales — total 878,577 USD

Planned sale 1 Apr 2026

Value US$439,288.26 | Price 449.17 | Shares 978

Proposed sale 1 Apr 2026

Value US$439,288.26 | Price 449.17 | Shares 978

Bozic Carmen

EVP and CMO

2 sales — total 2,100,525 USD

Planned sale 27 Mar 2026

Value US$1,050,262.55 | Price 450.95 | Shares 2,329

Proposed sale 27 Mar 2026

Value US$1,050,262.55 | Price 450.95 | Shares 2,329

Bozic Carmen

EVP and CMO

2 sales — total 2,244,178 USD

Planned sale 13 Mar 2026

Value US$1,122,088.91 | Price 481.79 | Shares 2,329

Proposed sale 13 Mar 2026

Value US$1,122,088.91 | Price 481.79 | Shares 2,329

McKechnie Duncan

EVP, Chief Commercial Officer

2 sales — total 2,624,680 USD

Planned sale 11 Mar 2026

Value US$1,312,339.86 | Price 498.42 | Shares 2,633

Proposed sale 11 Mar 2026

Value US$1,312,339.86 | Price 498.42 | Shares 2,633

McKechnie Duncan

EVP, Chief Commercial Officer

2 sales — total 2,316,612 USD

Planned sale 4 Mar 2026

Value US$1,158,306.10 | Price 475.30 | Shares 2,437

Proposed sale 4 Mar 2026

Value US$1,158,306.10 | Price 475.30 | Shares 2,437

Liu Joy

EVP and Chief Legal Officer

2 sales — total 884,793 USD

Planned sale 2 Mar 2026

Value US$442,396.32 | Price 495.96 | Shares 892

Proposed sale 2 Mar 2026

Value US$442,396.32 | Price 495.96 | Shares 892

Kewalramani Reshma

CEO & President

14 sales — total 39,477,760 USD

Planned sale 27 Feb 2026

Value US$857,238.75 | Price 496.95 | Shares 1,725

Planned sale 27 Feb 2026

Value US$2,974,479.20 | Price 496.16 | Shares 5,995

Planned sale 27 Feb 2026

Value US$7,718,020.40 | Price 495.38 | Shares 15,580

Planned sale 27 Feb 2026

Value US$1,729,166.34 | Price 494.33 | Shares 3,498

Planned sale 27 Feb 2026

Value US$1,243,090.80 | Price 493.29 | Shares 2,520

Planned sale 27 Feb 2026

Value US$466,243.70 | Price 491.30 | Shares 949

Planned sale 27 Feb 2026

Value US$1,336,721.50 | Price 490.54 | Shares 2,725

Planned sale 27 Feb 2026

Value US$225,087.20 | Price 489.32 | Shares 460

Planned sale 27 Feb 2026

Value US$1,600,549.06 | Price 488.27 | Shares 3,278

Planned sale 27 Feb 2026

Value US$1,222,696.30 | Price 487.13 | Shares 2,510

Planned sale 27 Feb 2026

Value US$115,881.60 | Price 482.84 | Shares 240

Planned sale 27 Feb 2026

Value US$57,780.00 | Price 481.50 | Shares 120

Planned sale 27 Feb 2026

Value US$191,900.00 | Price 479.75 | Shares 400

Proposed sale 27 Feb 2026

Value US$19,738,905.28 | Price 493.47 | Shares 40,000

Bozic Carmen

EVP and CMO

2 sales — total 2,237,284 USD

Planned sale 27 Feb 2026

Value US$1,118,641.99 | Price 480.31 | Shares 2,329

Proposed sale 27 Feb 2026

Value US$1,118,641.99 | Price 480.31 | Shares 2,329

Ambrose Kristen

SVP & Chief Accounting Officer

1 sale — total 172,560 USD

Planned sale 26 Feb 2026

Value US$172,559.52 | Price 483.36 | Shares 357

Tatsis Ourania

EVP, Chief Reg. & Quality Off.

2 sales — total 252,902 USD

Planned sale 25 Feb 2026

Value US$126,451.00 | Price 486.35 | Shares 260

Proposed sale 25 Feb 2026

Value US$126,451.00 | Price 486.35 | Shares 260

Sachdev Amit

EVP Chief Patient & Ext Af Off

2 sales — total 1,795,604 USD

Planned sale 25 Feb 2026

Value US$897,802.10 | Price 486.35 | Shares 1,846

Proposed sale 25 Feb 2026

Value US$897,802.10 | Price 486.35 | Shares 1,846

McKechnie Duncan

EVP, Chief Commercial Officer

3 sales — total 4,788,730 USD

Planned sale 25 Feb 2026

Value US$1,178,490.00 | Price 489.00 | Shares 2,410

Planned sale 25 Feb 2026

Value US$1,215,875.00 | Price 486.35 | Shares 2,500

Proposed sale 25 Feb 2026

Value US$2,394,365.00 | Price 487.65 | Shares 4,910

Bunnage Mark E.

EVP, Chief Scientific Officer

2 sales — total 603,074 USD

Planned sale 25 Feb 2026

Value US$301,537.00 | Price 486.35 | Shares 620

Proposed sale 25 Feb 2026

Value US$301,537.00 | Price 486.35 | Shares 620

Biller Jonathan

EVP and Chief Legal Officer

2 sales — total 919,202 USD

Planned sale 25 Feb 2026

Value US$459,600.75 | Price 486.35 | Shares 945

Proposed sale 25 Feb 2026

Value US$459,600.75 | Price 486.35 | Shares 945

Atkinson Edward Morrow III

EVP, Chief Technical Ops. Off.

2 sales — total 649,764 USD

Planned sale 25 Feb 2026

Value US$324,881.80 | Price 486.35 | Shares 668

Proposed sale 25 Feb 2026

Value US$324,881.80 | Price 486.35 | Shares 668

Ambrose Kristen

SVP & Chief Accounting Officer

1 sale — total 108,456 USD

Planned sale 25 Feb 2026

Value US$108,456.05 | Price 486.35 | Shares 223

Sachdev Amit

EVP Chief Patient & Ext Af Off

9 sales — total 54,959,159 USD

Planned sale 19 Feb 2026

Value US$1,997,448.91 | Price 471.43 | Shares 4,237

Planned sale 19 Feb 2026

Value US$5,510,964.48 | Price 470.54 | Shares 11,712

Planned sale 19 Feb 2026

Value US$3,400,446.01 | Price 469.61 | Shares 7,241

Planned sale 19 Feb 2026

Value US$9,213,023.34 | Price 468.57 | Shares 19,662

Planned sale 19 Feb 2026

Value US$4,800,518.25 | Price 467.75 | Shares 10,263

Planned sale 19 Feb 2026

Value US$860,798.40 | Price 465.80 | Shares 1,848

Planned sale 19 Feb 2026

Value US$1,269,586.50 | Price 465.05 | Shares 2,730

Planned sale 19 Feb 2026

Value US$426,797.20 | Price 463.91 | Shares 920

Proposed sale 19 Feb 2026

Value US$27,479,575.82 | Price 468.83 | Shares 58,613

Tatsis Ourania

EVP, Chief Reg. & Quality Off.

1 sale — total 174,314 USD

Planned sale 18 Feb 2026

Value US$174,314.24 | Price 473.68 | Shares 368

Bunnage Mark E.

EVP, Chief Scientific Officer

1 sale — total 559,890 USD

Planned sale 18 Feb 2026

Value US$559,889.76 | Price 473.68 | Shares 1,182

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-18	2026-06-18	PrS Proposed sale	Bozic Carmen Officer Officer	38,997 351.45 US$1,184,734	38,997	351.45	US$1,184,734
2026-06-17	2026-06-15	PlS Planned sale	Bozic Carmen EVP and CMO Officer	80,311 +41.8% 411.69 US$1,018,368	80,311 +41.8%	411.69	US$1,018,368
2026-06-17	2026-06-15	PlS Planned sale	Bozic Carmen EVP and CMO Officer	96,264 +41.9% 497.71 US$2,377,408	96,264 +41.9%	497.71	US$2,377,408
2026-06-15	2026-06-15	PrS Proposed sale	Bozic Carmen Officer Officer	1,000 450.00 US$100,000	1,000	450.00	US$100,000
2026-06-09	2026-06-05	PlS Planned sale	Bozic Carmen EVP and CMO Officer	1,000 -7.7% 450.00 US$100,000	1,000 -7.7%	450.00	US$100,000
2026-06-05	2026-06-05	PrS Proposed sale	Bozic Carmen Officer Officer	1,000 450.00 US$100,000	1,000	450.00	US$100,000
2026-06-03	2026-06-01	PlS Planned sale	Liu Joy EVP and Chief Legal Officer Officer	1,000 -4.0% 439.91 US$100,000	1,000 -4.0%	439.91	US$100,000
2026-06-01	2026-06-01	PrS Proposed sale	Liu Joy Officer Officer	828 439.91 US$364,245	828	439.91	US$364,245
2026-06-02	2026-05-29	PlS Planned sale	Bozic Carmen EVP and CMO Officer	1,000 -8.0% 450.00 US$100,000	1,000 -8.0%	450.00	US$100,000
2026-05-29	2026-05-29	PrS Proposed sale	Bozic Carmen Officer Officer	1,974 450.00 US$888,300	1,974	450.00	US$888,300
2026-05-19	2026-05-15	PlS Planned sale	Bozic Carmen EVP and CMO Officer	1,354 -5.2% 453.45 US$613,971	1,354 -5.2%	453.45	US$613,971
2026-05-19	2026-05-15	PlS Planned sale	Bunnage Mark E. EVP, Chief Scientific Officer Officer	33 -0.5% 453.45 US$14,964	33 -0.5%	453.45	US$14,964
2026-05-15	2026-05-15	PrS Proposed sale	Bozic Carmen Officer Officer	1,354 453.45 US$613,971	1,354	453.45	US$613,971
2026-05-15	2026-05-15	PrS Proposed sale	Bunnage Mark E. Officer Officer	33 453.45 US$14,964	33	453.45	US$14,964
2026-05-14	2026-05-12	PlS Planned sale	Bozic Carmen EVP and CMO Officer	6,988 -21.1% 450.00 US$3,144,600	6,988 -21.1%	450.00	US$3,144,600
2026-05-12	2026-05-12	PrS Proposed sale	Bozic Carmen Officer Officer	6,988 450.00 US$3,144,600	6,988	450.00	US$3,144,600
2026-05-06	2026-05-06	PrS Proposed sale	Biller Jonathan Officer Officer	5,193 424.25 US$2,203,149	5,193	424.25	US$2,203,149
2026-05-05	2026-05-04	PlS Planned sale	Bhatia Sangeeta N. Non-Executive Director	318 -6.1% 423.73 US$134,746	318 -6.1%	423.73	US$134,746
2026-05-04	2026-05-04	PrS Proposed sale	Bhatia Sangeeta N. Director Non-Executive Director	318 423.73 US$134,746	318	423.73	US$134,746
2026-05-05	2026-05-01	PlS Planned sale	Liu Joy EVP and Chief Legal Officer Officer	1,104 -5.1% 425.02 US$469,222	1,104 -5.1%	425.02	US$469,222
2026-05-01	2026-05-01	PrS Proposed sale	Liu Joy Officer Officer	1,104 425.02 US$469,222	1,104	425.02	US$469,222
2026-04-03	2026-04-01	PlS Planned sale	Liu Joy EVP and Chief Legal Officer Officer	978 -4.3% 449.17 US$439,288	978 -4.3%	449.17	US$439,288
2026-04-01	2026-04-01	PrS Proposed sale	Liu Joy Officer Officer	978 449.17 US$439,288	978	449.17	US$439,288
2026-03-31	2026-03-27	PlS Planned sale	Bozic Carmen EVP and CMO Officer	2,329 -6.6% 450.95 US$1,050,263	2,329 -6.6%	450.95	US$1,050,263
2026-03-27	2026-03-27	PrS Proposed sale	Bozic Carmen Officer Officer	2,329 450.95 US$1,050,263	2,329	450.95	US$1,050,263
2026-03-17	2026-03-13	PlS Planned sale	Bozic Carmen EVP and CMO Officer	2,329 -6.2% 481.79 US$1,122,089	2,329 -6.2%	481.79	US$1,122,089
2026-03-13	2026-03-13	PrS Proposed sale	Bozic Carmen Officer Officer	2,329 481.79 US$1,122,089	2,329	481.79	US$1,122,089
2026-03-13	2026-03-11	PlS Planned sale	McKechnie Duncan EVP, Chief Commercial Officer Officer	2,633 -17.4% 498.42 US$1,312,340	2,633 -17.4%	498.42	US$1,312,340
2026-03-11	2026-03-11	PrS Proposed sale	McKechnie Duncan Officer Officer	2,633 498.42 US$1,312,340	2,633	498.42	US$1,312,340
2026-03-06	2026-03-04	PlS Planned sale	McKechnie Duncan EVP, Chief Commercial Officer Officer	2,437 -13.9% 475.30 US$1,158,306	2,437 -13.9%	475.30	US$1,158,306
2026-03-04	2026-03-04	PrS Proposed sale	McKechnie Duncan Officer Officer	2,437 475.30 US$1,158,306	2,437	475.30	US$1,158,306
2026-03-04	2026-03-02	PlS Planned sale	Liu Joy EVP and Chief Legal Officer Officer	892 -3.8% 495.96 US$442,396	892 -3.8%	495.96	US$442,396
2026-03-02	2026-03-02	PrS Proposed sale	Liu Joy Officer Officer	892 495.96 US$442,396	892	495.96	US$442,396
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	1,725 -1.7% 496.95 US$857,239	1,725 -1.7%	496.95	US$857,239
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	5,995 -5.7% 496.16 US$2,974,479	5,995 -5.7%	496.16	US$2,974,479
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	15,580 -12.8% 495.38 US$7,718,020	15,580 -12.8%	495.38	US$7,718,020
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	3,498 -2.8% 494.33 US$1,729,166	3,498 -2.8%	494.33	US$1,729,166
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	2,520 -2.0% 493.29 US$1,243,091	2,520 -2.0%	493.29	US$1,243,091
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	949 -0.7% 491.30 US$466,244	949 -0.7%	491.30	US$466,244
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	2,725 -2.1% 490.54 US$1,336,722	2,725 -2.1%	490.54	US$1,336,722
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	460 -0.3% 489.32 US$225,087	460 -0.3%	489.32	US$225,087
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	3,278 -2.4% 488.27 US$1,600,549	3,278 -2.4%	488.27	US$1,600,549
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	2,510 -1.8% 487.13 US$1,222,696	2,510 -1.8%	487.13	US$1,222,696
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	240 -0.2% 482.84 US$115,882	240 -0.2%	482.84	US$115,882
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	120 -0.1% 481.50 US$57,780	120 -0.1%	481.50	US$57,780
2026-03-03	2026-02-27	PlS Planned sale	2.9 Kewalramani Reshma CEO & President Executive Director	400 -0.3% 479.75 US$191,900	400 -0.3%	479.75	US$191,900
2026-03-03	2026-02-27	PlS Planned sale	Bozic Carmen EVP and CMO Officer	2,329 -5.8% 480.31 US$1,118,642	2,329 -5.8%	480.31	US$1,118,642
2026-02-27	2026-02-27	PrS Proposed sale	2.9 Kewalramani Reshma Officer; Director Executive Director	40,000 493.47 US$19,738,905	40,000	493.47	US$19,738,905
2026-02-27	2026-02-27	PrS Proposed sale	Bozic Carmen Officer Officer	2,329 480.31 US$1,118,642	2,329	480.31	US$1,118,642
2026-03-02	2026-02-26	PlS Planned sale	Ambrose Kristen SVP & Chief Accounting Officer Officer	357 -5.1% 483.36 US$172,560	357 -5.1%	483.36	US$172,560
2026-02-26	2026-02-25	PlS Planned sale	Tatsis Ourania EVP, Chief Reg. & Quality Off. Officer	260 -0.6% 486.35 US$126,451	260 -0.6%	486.35	US$126,451
2026-02-26	2026-02-25	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	1,846 -3.2% 486.35 US$897,802	1,846 -3.2%	486.35	US$897,802
2026-02-26	2026-02-25	PlS Planned sale	McKechnie Duncan EVP, Chief Commercial Officer Officer	2,410 -12.1% 489.00 US$1,178,490	2,410 -12.1%	489.00	US$1,178,490
2026-02-26	2026-02-25	PlS Planned sale	McKechnie Duncan EVP, Chief Commercial Officer Officer	2,500 -11.1% 486.35 US$1,215,875	2,500 -11.1%	486.35	US$1,215,875
2026-02-26	2026-02-25	PlS Planned sale	Bunnage Mark E. EVP, Chief Scientific Officer Officer	620 -7.8% 486.35 US$301,537	620 -7.8%	486.35	US$301,537
2026-02-26	2026-02-25	PlS Planned sale	Biller Jonathan EVP and Chief Legal Officer Officer	945 -6.5% 486.35 US$459,601	945 -6.5%	486.35	US$459,601
2026-02-26	2026-02-25	PlS Planned sale	Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Officer	668 -3.5% 486.35 US$324,882	668 -3.5%	486.35	US$324,882
2026-02-26	2026-02-25	PlS Planned sale	Ambrose Kristen SVP & Chief Accounting Officer Officer	223 -3.1% 486.35 US$108,456	223 -3.1%	486.35	US$108,456
2026-02-25	2026-02-25	PrS Proposed sale	McKechnie Duncan Officer Officer	4,910 487.65 US$2,394,365	4,910	487.65	US$2,394,365
2026-02-25	2026-02-25	PrS Proposed sale	Tatsis Ourania Officer Officer	260 486.35 US$126,451	260	486.35	US$126,451
2026-02-25	2026-02-25	PrS Proposed sale	Bunnage Mark E. Officer Officer	620 486.35 US$301,537	620	486.35	US$301,537
2026-02-25	2026-02-25	PrS Proposed sale	Atkinson Edward Morrow III Officer Officer	668 486.35 US$324,882	668	486.35	US$324,882
2026-02-25	2026-02-25	PrS Proposed sale	Sachdev Amit Officer Officer	1,846 486.35 US$897,802	1,846	486.35	US$897,802
2026-02-25	2026-02-25	PrS Proposed sale	Biller Jonathan Officer Officer	945 486.35 US$459,601	945	486.35	US$459,601
2026-02-23	2026-02-19	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	4,237 -6.7% 471.43 US$1,997,449	4,237 -6.7%	471.43	US$1,997,449
2026-02-23	2026-02-19	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	11,712 -15.6% 470.54 US$5,510,964	11,712 -15.6%	470.54	US$5,510,964
2026-02-23	2026-02-19	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	7,241 -8.8% 469.61 US$3,400,446	7,241 -8.8%	469.61	US$3,400,446
2026-02-23	2026-02-19	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	19,662 -19.3% 468.57 US$9,213,023	19,662 -19.3%	468.57	US$9,213,023
2026-02-23	2026-02-19	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	10,263 -9.2% 467.75 US$4,800,518	10,263 -9.2%	467.75	US$4,800,518
2026-02-23	2026-02-19	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	1,848 -1.6% 465.80 US$860,798	1,848 -1.6%	465.80	US$860,798
2026-02-23	2026-02-19	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	2,730 -2.3% 465.05 US$1,269,586	2,730 -2.3%	465.05	US$1,269,586
2026-02-23	2026-02-19	PlS Planned sale	Sachdev Amit EVP Chief Patient & Ext Af Off Officer	920 -0.8% 463.91 US$426,797	920 -0.8%	463.91	US$426,797
2026-02-19	2026-02-19	PrS Proposed sale	Sachdev Amit Officer Officer	58,613 468.83 US$27,479,576	58,613	468.83	US$27,479,576
2026-02-19	2026-02-18	PlS Planned sale	Tatsis Ourania EVP, Chief Reg. & Quality Off. Officer	368 -0.8% 473.68 US$174,314	368 -0.8%	473.68	US$174,314
2026-02-19	2026-02-18	PlS Planned sale	Bunnage Mark E. EVP, Chief Scientific Officer Officer	1,182 -12.2% 473.68 US$559,890	1,182 -12.2%	473.68	US$559,890